Join Mount Sinai's Clinical Research Forum with guest speakers from MSIP: Cynthia Cleto, Assistant Director, Marketing & Outreach, and Paul Matri, Associate Director, Contracts & Licensing. The Forum facilitates communications between research personnel and administrative offices that regulate research projects.
Biopharmaceutical companies make some of the biggest and most risky gambles of any industry, as each new drug ultimately requires multi-billion-dollar investments that can take more than a decade to play out. During this time, profound changes may occur; Internal portfolios wax and wane, competitor innovations emerge, regulatory & commercial frameworks reshape the playing field, and in some cases therapeutic advancements move the pitch to a new field altogether.
In such an uncertain landscape, companies are constantly rethinking their strategy, and how they can take advantage of technical advancements to build innovation models that are fit for the future. With the emergence of open innovation networks, what will be the role for in-house R&D? What will the future of biopharma innovation look like?
This half-day workshop is directed at graduate students, postdocs, and others with an interest in understanding the innovation dynamics of the biopharmaceutical industry. It will provide a snapshot of how investment decisions are taken--beating competitors to a lucrative deal--and the challenges the industry faces. Using a competitive board game that has been developed specifically to mimic the pharmaceutical industry past and present, participants will take on the role of an executive team of a mid-size company. As a management team, they will develop, execute, alter their strategy in response to successes and failures, and pounce on the missed opportunities of others. At the end of the workshop, the winning team will be invited to share their strategy. Major lessons learned and key questions for the future will be summarized and opened for discussion.
Using a uniquely immersive and playful format, this workshop will guide you through the industry's past and present, and invite you to ponder the possibilities that lie in the future. Join a diverse group of participants across industry, academia, and healthcare to explore the "risky business" of the biopharmaceutical industry!
The discoveries of modern science tell an epic story of the universe through its fourteen-billion-year history. Though modern humans are relative newcomers to this story, having only appeared some 200,000 years ago, what meaning can we glean from the history of the cosmos? From the birth of galaxies to the self-organizing dynamics of our planet to the ongoing expansion of the universe, the more we discover about the evolution of the cosmos, the more acutely we realize the enormity of what remains to be known. Remarkably, over the past 100 years we have learned more about life in our universe than the entire history of humanity put together. Just this year astrophysicists at the University of Nottingham confirmed that there at least two trillion galaxies in the cosmos, ten times more than had previously been thought. And with over 90% of these galaxies yet to be studied, astrobiologists are hunting with renewed vigor for the existence of intelligent life on other planets. What guidance or wisdom can the study of cosmology and astrophysics offer us in our search for meaning and purpose? Theoretical physicists Paul Davies and Ard Louis, and astrophysicists Joel Primack and Lucianne Walkowicz tackle the “big questions” of existence — sharing their perceptions based on years of gazing upward and beyond our own intimate planet.
Cell death is a key driver of human disease. Processes linked to cell death, such as autophagy, further impact immune function, compounding disease pathology. Non-apoptotic cell death modalities (pyroptosis and necroptosis) are currently being investigated as opportunities for therapeutic intervention; however, the molecular pathways and physiological mechanisms controlling the dysfunction are ill-defined. In order to address this important knowledge gap, this symposium will present breaking research mapping the mechanisms by which cell death contributes to homeostasis and human disease, including mechanisms of cell clearance, the impact on pathogenesis and the implication for therapeutics.
Call for Abstracts
Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, January 19, 2018.